Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies

Nutrition

Volumn 57, Issue , 2019, Pages 5-11

  Zhao, Junyu ^a   Wang, Haipeng ^b   Zhang, Zhongwen ^a   Zhou, Xiaojun ^a   Yao, Jinming ^a   Zhang, Rui ^a   Liao, Lin ^a   Dong, Jianjun ^c  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

25 Hydoxyvitamin D; Case control study; Meta analysis; Thyroid cancer; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D;

CANCER RISK; CLINICAL FEATURE; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; THYROID CANCER; THYROIDECTOMY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; CASE CONTROL STUDY; COMPLICATION; META ANALYSIS; RISK FACTOR; THYROID TUMOR;

CASE-CONTROL STUDIES; HUMANS; RISK FACTORS; THYROID NEOPLASMS; VITAMIN D DEFICIENCY;

EID: 85050918570     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2018.04.015     Document Type: Review

References (41)

1. Siegel, R, Ma, J, Zou, Z, Jemal, A, Cancer statistics. CA Cancer J Clin 64 (2014), 9–29.
2. Davies, L, Welch, HG, Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140 (2014), 317–322.
3. Zheng, R, Zeng, H, Zhang, S, Chen, W, Estimates of cancer incidence and mortality in China, 2013. Chin J Cancer, 36, 2017, 66.
4. Sherman, S.I., Thyroid carcinoma. Lancet 361 (2003), 501–511.
5. Nagataki, S., Nystrom, E, Epidemiology and primary prevention of thyroid cancer. Thyroid 12 (2002), 889–896.
6. Lee, S, Morimoto, S, Onishi, T, Tsuji, M, Okada, Y, Seino, Y, Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid. J Clin Endocrinol Metab 55 (1982), 361–363.
7. Toivonen, J, Tähtelä, R, Laitinen, K, Risteli, J, Välimäki, MJ, Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy. Eur J Endocrinol 138 (1998), 667–673.
8. Laney, N, Meza, J, Lyden, E, Erickson, J, Treude, K, Goldner, W, The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. Int J Endocrinol, 2010, 2010, 805716.
9. Stepien, T, Krupinski, R, Sopinski, J, Kuzdak, K, Komorowski, J, Lawnicka, H, et al. Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer. Arch Med Res 41 (2010), 190–194.
10. Roskies, M, Dolev, Y, Caglar, D, Hier, MP, Mlynarek, A, Majdan, A, et al. Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg 41 (2012), 160–163.
11. Penna-Martinez, M, Ramos-Lopez, E, Stern, J, Kahles, H, Hinsch, N, Hansmann, ML, et al. Impaired vitamin D activation and association with CYP24 A1 haplotypes in differentiated thyroid carcinoma. Thyroid 22 (2012), 709–716.
12. Jonklaas, J, Danielsen, M, Wang, H, A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid 23 (2013), 1079–1086.
13. Sahin, M, Uçan, B, Giniş, Z, Topaloğlu, O, Güngüneş, A, Bozkurt, NÇ, et al. Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol, 30, 2013, 589.
14. Danilovic, DL, Ferraz-de-Souza, B, Fabri, AW, Santana, NO, Kulcsar, MA, Cernea, CR, et al. 25-Hydroxyvitamin D and TSH as risk factors or prognostic markers in thyroid carcinoma. PLoS One, 11, 2016, e0164550.
15. Yanyan, J, Correlation of 25-hydroxy vitaminD3 and insulin resistance with papillary thyroid carcinoma. J Chongqing Med Univ 41 (2016), 1276–1279.
16. Jianbo, Y, Serum 25-hydroxy vitamin D and haptoglobin level in female patients with papillary thyroid carcinoma and its clinical significance. Pract J Cancer 31 (2016), 901–904.
17. Choi, YM, Kim, WG, Kim, TY, Bae, SJ, Kim, HK, Jang, EK, et al. Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease. Korean J Intern Med 32 (2017), 102–108.
18. Heidari, Z, Nikbakht, M, Mashhadi, MA, Jahantigh, M, Mansournia, N, Sheikhi, V, et al. Vitamin D deficiency associated with differentiated thyroid carcinoma: a case–control study. Asian Pac J Cancer Prev 18 (2017), 3419–3422.
19. Kachui, A, Tabatabaizadeh, SM, Iraj, B, Rezvanian, H, Feizi, A, Evaluation of bone density, serum total and ionized calcium, alkaline phosphatase and 25-hydroxy vitamin D in papillary thyroid carcinoma, and their relationship with TSH suppression by levothyroxine. Adv Biomed Res, 6, 2017, 94.
20. Deeb, KK, Trump, DL, Johnson, CS, Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7 (2007), 684–700.
21. Jung, KW, Won, YJ, Oh, CM, Kong, HJ, Lee, DH, Lee, KH, Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat 49 (2017), 292–305.
22. Morris, LG, Tuttle, RM, Davies, L, Changing trends in the incidence of thyroid cancer in the United States. JAMA Otolaryngol Head Neck Surg 207 (2016), 1350–1359.
23. Rezzónico, JN, Rezzónico, M, Pusiol, E, Pitoia, F, Niepomniszcze, H, Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 7 (2009), 375–380.
24. Biondi, B, Arpaia, D, Montuori, P, Ciancia, G, Ippolito, S, Pettinato, G, et al. Under the shadow of vesuvius: a risk for thyroid cancer?. Thyroid 22 (2012), 1296–1297.
25. Pellegriti, G, De Vathaire, F, Scollo, C, Attard, M, Giordano, C, Arena, S, et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst 101 (2009), 1575–1583.
26. Jung, SK, Kim, K, Tae, K, Kong, G, Kim, MK, The effect of raw vegetable and fruit intake on thyroid cancer risk among women: a case–control study in South Korea. Br J Nutr 109 (2013), 118–128.
27. Davis, CD, Vitamin D and cancer current dilemmas and future research needs. Am J Clin Nutr 88 (2008), 565S–569S.
28. Laird, E, McNulty, H, Ward, M, Hoey, L, McSorley, E, Wallace, JM, et al. Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab 99 (2014), 1807–1815.
29. Zanetti, M, Harris, SS, Dawson-Hughes, B, Ability of vitamin D to reduce inflammation in adults without acute illness. Nutr Rev 72 (2014), 95–98.
30. Clinckspoor, I, Verlinden, L, Mathieu, C, Bouillon, R, Verstuyf, A, Decallonne, B, Vitamin D in thyroid tumorigenesis and development. Prog Histochem Cytochem 48 (2013), 65–98.
31. Muzza, M, Degl'Innocenti, D, Colombo, C, Perrino, M, Ravasi, E, Rossi, S, et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 72 (2010), 702–708.
32. Guarino, V, Castellone, MD, Avilla, E, Melillo, RM, Thyroid cancer and inflammation. Mol Cell Endocrinol 321 (2010), 94–102.
33. Sica, A, Allavena, P, Mantovani, A, Cancer related inflammation: the macrophage connection. Cancer Lett 267 (2008), 204–215.
34. Puxeddu, E, Knauf, JA, Sartor, MA, Mitsutake, N, Smith, EP, Medvedovic, M, et al. RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response. Endocr Relat Cancer 12 (2005), 319–334.
35. Díaz, GD, Paraskeva, C, Thomas, MG, Binderup, L, Hague, A, Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 60 (2000), 2304–2312.
36. Pálmer, HG, Sánchez-Carbayo, M, Ordóñez-Morán, P, Larriba, MJ, Cordón-Cardó, C, Muñoz, A, Genetic signatures of differentiation induced by1 alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 63 (2003), 7799–7806.
37. Lainey, E, Wolfromm, A, Sukkurwala, AQ, Micol, JB, Fenaux, P, Galluzzi, L, et al. EGFR inhibitors exacerbate differentiation and cell cyclearrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell Cycle (Georgetown, Tex) 12 (2013), 2978–2991.
38. Garcia-Quiroz, J, Rivas-Suarez, M, Garcia-Becerra, R, Barrera, D, Martinez-Reza, I, Ordaz-Rosado, D, et al. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis. J Steroid Biochem Mol Biol 144 (2014), 215–222.
39. Passler, C, Scheuba, C, Prager, G, Kaczirek, K, Kaserer, K, Zettinig, G, et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 11 (2004), 131–139.
40. Hansen, CM, Binderup, L, Hamberg, KJ, Carlberg, C, Vitamin D and cancer: effects of 1,25(OH)2 D3 and its analogs on growth control and tumorigenesis. Front Biosci 6 (2001), D820–D848.
41. Giovannucci, E, Vitamin D and status cancer incidence and mortality. Adv Exp Med Biol 624 (2008), 31–42.